Clinical Trials Browser

Phase 1 × eltrombopag × Clear all

Solid Tumor, Childhood

NCT04542382 2025-03-30

BCRPmarker

Phase 1 Completed

11 enrolled

Healthy Volunteers

NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Phase 1 Completed

16 enrolled

Healthy Adults

NCT01550185 2022-07-22

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Terminated

10 enrolled

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00358540 2017-11-13

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Phase 1 Completed

18 enrolled

Classical hematologySarcoma

Sarcoma, Thrombocytopenia

NCT01491594 2014-04-02

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Phase 1 Terminated

1 enrolled

Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

Clinical Trials

CCPO011

BCRPmarker

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia